Carbonic	carbonic	JJ	O
anhydrases	anhydrase	NNS	O
are	be	VBP	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
metalloenzymes	metalloenzymes	NNP	O
catalysing	catalyse	VBG	O
the	the	DT	O
hydration	hydration	NN	O
process	process	NN	O
of	of	IN	O
CO2	CO2	NNP	O
to	to	TO	O
HCO3â	HCO3â	NNP	O
and	and	CC	O
H+	h+	ADD	O
.	.	.	O

All	all	DT	O
living	live	VBG	O
organisms	organism	NNS	O
contain	contain	VBP	O
CAs	ca	NNS	O
encoded	encode	VBD	O
by	by	IN	O
six	six	CD	O
phylogenetically	phylogenetically	RB	O
gene	gene	NN	O
families	family	NNS	O
.	.	.	B
,	,	,	B
Fifteen	fifteen	CD	O
CA	CA	NNP	O
isoenzymes	isoenzyme	NNS	O
belonging	belong	VBG	O
to	to	IN	O
Î±-CA	Î±-CA	NNP	O
gene	gene	NN	O
family	family	NN	O
have	have	VBP	O
been	be	VBN	O
characterised	characterise	VBN	O
in	in	IN	O
human	human	NN	O
-	-	HYPH	O
beings	being	NNS	O
.	.	.	O

Some	some	DT	O
human	human	JJ	O
CA	CA	NNP	O
isoenzymes	isoenzyme	NNS	O
are	be	VBP	O
cytosolic	cytosolic	JJ	O
isoforms	isoform	NNS	O
,	,	,	O
some	some	DT	O
isoenzymes	isoenzyme	NNS	O
are	be	VBP	O
membrane	membrane	NN	O
-	-	HYPH	O
bound	bind	VBN	O
isoforms	isoform	NNS	O
,	,	,	O
both	both	DT	O
hCA	hCA	VBD	O
VA	VA	NNP	O
and	and	CC	O
VB	VB	NNP	O
are	be	VBP	O
mitochondrial	mitochondrial	JJ	O
isoforms	isoform	NNS	O
and	and	CC	O
hCA	hCA	VBZ	O
VI	VI	NNP	O
isoform	isoform	NN	O
is	be	VBZ	O
involved	involve	VBN	O
in	in	IN	O
saliva	saliva	NN	O
.	.	.	O

Three	three	CD	O
hCA	hca	NN	O
isoenzymes	isoenzyme	NNS	O
are	be	VBP	O
characterised	characterise	VBN	O
as	as	IN	O
acatalytic	acatalytic	JJ	O
protein	protein	NN	O
forms	form	NNS	O
.	.	.	O

Inhibition	inhibition	NN	O
and	and	CC	O
activation	activation	NN	O
studies	study	NNS	O
on	on	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
of	of	IN	O
CAs	ca	NNS	O
are	be	VBP	O
crucial	crucial	JJ	O
for	for	IN	O
the	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
numerous	numerous	JJ	O
clinically	clinically	RB	O
important	important	JJ	O
diseases	disease	NNS	O
.	.	.	B
,	,	,	B
The	the	DT	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
CA	CA	NNP	O
isoenzymes	isoenzyme	NNS	O
are	be	VBP	O
used	use	VBN	O
to	to	TO	O
design	design	VB	O
new	new	JJ	O
class	class	NN	O
of	of	IN	O
drugs	drug	NNS	O
for	for	IN	O
epilepsy	epilepsy	NN	O
and	and	CC	O
glaucoma	glaucoma	NN	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
new	new	JJ	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
have	have	VBP	O
been	be	VBN	O
required	require	VBN	O
to	to	TO	O
develop	develop	VB	O
as	as	IN	O
therapeutic	therapeutic	JJ	O
agents	agent	NNS	O
.	.	.	B
Several	several	JJ	O
groups	group	NNS	O
have	have	VBP	O
studied	study	VBN	O
the	the	DT	O
inhibition	inhibition	NN	O
of	of	IN	O
hCAs	hCAs	``	O
with	with	IN	O
anions	anion	NNS	O
,	,	,	B
catecholamines	catecholamine	NNS	O
,	,	,	B
thiourea	thiourea	NNP	O
derivatives	derivative	NNS	O
,	,	,	B
uracil	uracil	NN	O
derivatives	derivative	NNS	O
,	,	,	B
bromophenols	bromophenol	VBZ	B
and	and	CC	O
sulphonamides	sulphonamide	NNS	O
.	.	.	B
In	in	IN	O
addition	addition	NN	O
,	,	,	O
pyrazoles	pyrazole	NNS	O
and	and	CC	O
chalcones	chalcone	NNS	O
have	have	VBP	O
also	also	RB	O
been	be	VBN	O
studied	study	VBN	O
to	to	TO	O
inhibit	inhibit	VB	O
hCAs	hcas	XX	O
as	as	RB	O
well	well	RB	O
.	.	.	O

CYTOWANIEHeterocyclic	cytowanieheterocyclic	JJ	O
compounds	compound	NNS	O
have	have	VBP	O
a	a	DT	O
vital	vital	JJ	O
role	role	NN	O
in	in	IN	O
medicine	medicine	NN	O
,	,	,	O
pharmacy	pharmacy	NN	O
and	and	CC	O
agriculture	agriculture	NN	O
.	.	.	B
Pyrazoles	Pyrazoles	NNPS	O
possess	possess	VBP	O
various	various	JJ	O
important	important	JJ	O
bio	bio	JJ	O
-	-	JJ	O
medical	medical	JJ	O
features	feature	NNS	O
.	.	.	B
This	this	DT	O
type	type	NN	O
of	of	IN	O
derivatives	derivative	NNS	O
exhibits	exhibit	VBZ	O
several	several	JJ	O
therapeutic	therapeutic	JJ	O
activities	activity	NNS	O
such	such	JJ	O
as	as	IN	O
insecticidal	insecticidal	RB	O
,	,	,	B
acaricidal	acaricidal	NN	O
,	,	,	B
anticonvulsant	anticonvulsant	NN	B
antidepressant	antidepressant	NN	O
,	,	,	B
antiulcer	antiulcer	NN	O
,	,	,	O
and	and	CC	O
anticancer	anticancer	NN	O
features	feature	NNS	O
.	.	.	B
So	so	RB	O
far	far	RB	O
to	to	IN	O
date	date	NN	O
,	,	,	O
many	many	JJ	O
chalcone	chalcone	NN	O
derivatives	derivative	NNS	O
have	have	VBP	O
been	be	VBN	O
synthesised	synthesise	VBN	O
and	and	CC	O
their	-PRON-	PRP$	O
biological	biological	JJ	O
activities	activity	NNS	O
examined	examine	VBD	O
.	.	.	B
Several	several	JJ	O
investigations	investigation	NNS	O
have	have	VBP	O
shown	show	VBN	O
that	that	IN	O
chalcones	chalcone	NNS	O
possess	possess	VBP	O
important	important	JJ	O
pharmacological	pharmacological	JJ	O
characteristics	characteristic	NNS	O
including	include	VBG	O
antitumor	antitumor	NN	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
inflammatory	inflammatory	JJ	O
,	,	,	O
antifungal	antifungal	JJ	O
and	and	CC	O
antioxidant	antioxidant	JJ	O
properties	property	NNS	O
.	.	.	B
The	the	DT	O
development	development	NN	O
of	of	IN	O
effective	effective	JJ	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
is	be	VBZ	O
limited	limit	VBN	O
by	by	IN	O
the	the	DT	O
lack	lack	NN	O
of	of	IN	O
selectivity	selectivity	NN	O
which	which	WDT	O
could	could	MD	O
lead	lead	VB	O
to	to	IN	O
serious	serious	JJ	O
side	side	NN	O
effects	effect	NNS	O
.	.	.	B
Hence	hence	RB	O
,	,	,	O
it	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
of	of	IN	O
interest	interest	NN	O
to	to	IN	O
us	-PRON-	PRP	O
to	to	TO	O
develop	develop	VB	O
not	not	RB	O
only	only	RB	O
potent	potent	JJ	O
hCA	hca	NN	O
inhibitors	inhibitor	NNS	O
but	but	CC	O
also	also	RB	O
with	with	IN	O
a	a	DT	O
promising	promising	JJ	O
selectivity	selectivity	NN	O
for	for	IN	O
a	a	DT	O
specific	specific	JJ	O
isoform	isoform	NN	O
.	.	.	O

We	-PRON-	PRP	O
have	have	VBP	O
previously	previously	RB	O
carried	carry	VBN	O
out	out	RP	O
synthesis	synthesis	NN	O
of	of	IN	O
various	various	JJ	O
phenols	phenol	NNS	O
and	and	CC	O
methoxyphenols	methoxyphenol	NNS	O
in	in	IN	O
addition	addition	NN	O
to	to	IN	O
derivatives	derivative	NNS	O
of	of	IN	O
some	some	DT	O
natural	natural	JJ	O
products	product	NNS	O
which	which	WDT	O
possess	possess	VBP	O
different	different	JJ	O
structures	structure	NNS	O
.	.	.	B
Some	some	DT	O
of	of	IN	O
our	-PRON-	PRP$	O
recently	recently	RB	O
synthesised	synthesise	VBN	O
compounds	compound	NNS	O
were	be	VBD	O
found	find	VBN	O
to	to	TO	O
inhibit	inhibit	VB	O
CAs	ca	NNS	O
in	in	IN	O
the	the	DT	O
milimolar	milimolar	NN	O
to	to	IN	O
low	low	JJ	O
nanomolar	nanomolar	JJ	O
ranges	range	NNS	O
.	.	.	B
In	in	IN	O
the	the	DT	O
current	current	JJ	O
study	study	NN	O
,	,	,	O
we	-PRON-	PRP	O
focussed	focusse	VBD	O
on	on	IN	O
the	the	DT	O
synthesis	synthesis	NN	O
and	and	CC	O
inhibitory	inhibitory	JJ	O
effects	effect	NNS	O
of	of	IN	O
some	some	DT	O
pyrazole	pyrazole	NN	O
derivatives	derivative	NNS	O
against	against	IN	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
and	and	CC	O
II	ii	CD	O
isoforms	isoform	NNS	O
.	.	.	O

Computational	computational	JJ	O
studies	study	NNS	O
were	be	VBD	O
also	also	RB	O
used	use	VBN	O
to	to	TO	O
enlighten	enlighten	VB	O
their	-PRON-	PRP$	O
activities	activity	NNS	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
binding	bind	VBG	O
interactions	interaction	NNS	O
with	with	IN	O
the	the	DT	O
target	target	NN	O
enzymes	enzyme	NNS	O
and	and	CC	O
their	-PRON-	PRP$	O
calculated	calculate	VBN	O
molecular	molecular	JJ	O
properties.1H	properties.1H	NNP	O
and	and	CC	O
13âC	13âC	NNP	O
spectra	spectra	NNP	O
were	be	VBD	O
recorded	record	VBN	O
on	on	IN	O
Bruker	Bruker	NNP	O
Ascend	Ascend	NNP	O
400	400	CD	O
âMHz	âMHz	NNP	O
spectrometers	spectrometer	NNS	O
and	and	CC	O
chemical	chemical	NN	O
shifts	shift	NNS	O
were	be	VBD	O
reported	report	VBN	O
Î	Î	NNP	O
»	»	NNP	O
relative	relative	JJ	O
to	to	IN	O
Me4Si	Me4Si	NNP	O
as	as	IN	O
internal	internal	JJ	O
standard	standard	NN	O
.	.	.	O

The	the	DT	O
elemental	elemental	JJ	O
analyses	analysis	NNS	O
were	be	VBD	O
performed	perform	VBN	O
on	on	IN	O
a	a	DT	O
Costech	Costech	NNP	O
ESC	ESC	NNP	O
4010	4010	CD	O
instrument	instrument	NN	O
.	.	.	O

The	the	DT	O
IR	IR	NNP	O
spectra	spectra	NN	O
were	be	VBD	O
determined	determine	VBN	O
using	use	VBG	O
a	a	DT	O
Perkin	Perkin	NNP	O
Elmer	Elmer	NNP	O
1600	1600	CD	O
Fourier	Fourier	NNP	O
Transform	Transform	NNP	O
-	-	HYPH	O
infrared	infrare	VBN	O
spectrophotometer	spectrophotometer	NN	O
on	on	IN	O
a	a	DT	O
KBr	KBr	VBN	O
disc	disc	NN	O
.	.	.	O

Melting	melt	VBG	O
points	point	NNS	O
were	be	VBD	O
determined	determine	VBN	O
by	by	IN	O
using	use	VBG	O
a	a	DT	O
Barnstead	Barnstead	NNP	O
electrothermal	electrothermal	JJ	O
9200	9200	CD	O
series	series	NN	O
digital	digital	JJ	O
apparatus	apparatus	NN	O
.	.	.	O

Absorption	absorption	NN	O
spectra	spectra	NNP	O
were	be	VBD	O
recorded	record	VBN	O
on	on	IN	O
a	a	DT	O
Shimadzu	Shimadzu	NNP	O
UV-1800	UV-1800	NNP	O
spectrophotometer	spectrophotometer	NN	O
.	.	.	O

CA	CA	NNP	O
esterase	esterase	NN	O
activity	activity	NN	O
was	be	VBD	O
determined	determine	VBN	O
according	accord	VBG	O
to	to	IN	O
Verpoorte	Verpoorte	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	O

CYTOWANIEAn	CYTOWANIEAn	NNP	O
aqueous	aqueous	JJ	O
solution	solution	NN	O
of	of	IN	O
NaOH	NaOH	NNP	O
60	60	CD	O
%	%	NN	O
,	,	,	O
10âml	10âml	CD	O
was	be	VBD	O
added	add	VBN	O
into	into	IN	O
the	the	DT	O
ethanol	ethanol	NN	O
6âml	6âml	CD	O
solution	solution	NN	O
of	of	IN	O
substituted	substitute	VBN	O
carbaldehyde	carbaldehyde	NN	O
20.0âmmol	20.0âmmol	NNP	O
and	and	CC	O
a	a	DT	O
suitable	suitable	JJ	O
acetophenone	acetophenone	NN	O
20.0âmmol	20.0âmmol	NNP	O
.	.	.	O

The	the	DT	O
mixture	mixture	NN	O
was	be	VBD	O
stirred	stir	VBN	O
for	for	IN	O
a	a	DT	O
day	day	NN	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
and	and	CC	O
it	-PRON-	PRP	O
was	be	VBD	O
then	then	RB	O
poured	pour	VBN	O
on	on	IN	O
ice	ice	NN	O
-	-	HYPH	O
water	water	NN	O
.	.	.	O

The	the	DT	O
mixture	mixture	NN	O
was	be	VBD	O
neutralised	neutralise	VBN	O
using	use	VBG	O
6âM	6âm	CD	O
hydrochloric	hydrochloric	JJ	O
acid	acid	NN	O
.	.	.	O

The	the	DT	O
yellow	yellow	JJ	O
precipitate	precipitate	NN	O
obtained	obtain	VBN	O
was	be	VBD	O
filtered	filter	VBN	O
and	and	CC	O
crystallized	crystallize	VBN	O
from	from	IN	O
ethanol	ethanol	NN	O
-	-	HYPH	O
water	water	NN	O
.	.	.	O

-1	-1	:	O
-	-	:	O
-3-prop-2-en-1-one	-3-prop-2-en-1-one	CD	O
,	,	,	O
-1	-1	:	O
-	-	:	O
-3-prop-2-en-1-one	-3-prop-2-en-1-one	CD	O
,	,	,	O
-1-p	-1-p	:	O
-	-	HYPH	O
tolyl-3-prop-2-en-1-one	tolyl-3-prop-2-en-1-one	NN	O
,	,	,	O
-1	-1	NNP	O
-	-	:	O
-3-prop-2-en-1-one	-3-prop-2-en-1-one	JJS	O
,	,	,	O
-3-(4-phenyl)-1-prop-2-en-1-one	-3-(4-phenyl)-1-prop-2-en-1-one	:	O
were	be	VBD	O
synthesised	synthesise	VBN	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
literature	literature	NN	O
,	,	,	B
respectively	respectively	RB	O
.	.	.	O

A	a	DT	O
mixture	mixture	NN	O
of	of	IN	O
0.007âmol	0.007âmol	NN	O
chalcone	chalcone	NN	O
and	and	CC	O
0.014âmol	0.014âmol	NN	O
thiosemicarbazide	thiosemicarbazide	NNP	O
were	be	VBD	O
refluxed	refluxe	VBN	O
in	in	IN	O
ethanol	ethanol	NN	O
15âml	15âml	CD	O
while	while	IN	O
stirring	stir	VBG	O
vigorously	vigorously	RB	O
.	.	.	O

After	after	IN	O
complete	complete	JJ	O
dissolution	dissolution	NN	O
of	of	IN	O
the	the	DT	O
reactants	reactant	NNS	O
,	,	,	O
a	a	DT	O
solution	solution	NN	O
of	of	IN	O
0.014âmol	0.014âmol	NN	O
of	of	IN	O
KOH	KOH	NNP	O
in	in	IN	O
ethanol	ethanol	NN	O
15âml	15âml	CD	O
was	be	VBD	O
added	add	VBN	O
dropwise	dropwise	NN	O
.	.	.	O

The	the	DT	O
solution	solution	NN	O
was	be	VBD	O
refluxed	refluxe	VBN	O
for	for	IN	O
another	another	DT	O
18âh	18âh	CD	O
,	,	,	O
allowed	allow	VBN	O
to	to	TO	O
warm	warm	VB	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
and	and	CC	O
then	then	RB	O
stirred	stir	VBD	O
for	for	IN	O
4âh	4âh	CD	O
.	.	.	O

The	the	DT	O
crude	crude	JJ	O
product	product	NN	O
was	be	VBD	O
refrigerated	refrigerate	VBN	O
overnight	overnight	RB	O
.	.	.	O

The	the	DT	O
precipitate	precipitate	NN	O
formed	form	VBN	O
was	be	VBD	O
filtered	filter	VBN	O
off	off	RP	O
and	and	CC	O
crystallized	crystallize	VBN	O
from	from	IN	O
ethanol	ethanol	NN	O
twice	twice	RB	O
yielding	yield	VBG	O
yellow	yellow	JJ	O
crystals	crystal	NNS	O
.	.	.	O

Enzyme	Enzyme	NNS	O
activity	activity	NN	O
was	be	VBD	O
determined	determine	VBN	O
spectrophotometrically	spectrophotometrically	RB	O
by	by	IN	O
following	follow	VBG	O
the	the	DT	O
change	change	NN	O
in	in	IN	O
absorbance	absorbance	NN	O
at	at	IN	O
348ânm	348ânm	CD	O
of	of	IN	O
4-nitrophenylacetate	4-nitrophenylacetate	CD	O
to	to	TO	O
4-nitrophenolate	4-nitrophenolate	CD	O
over	over	IN	O
a	a	DT	O
period	period	NN	O
of	of	IN	O
3âmin	3âmin	CD	O
at	at	IN	O
25âÂ	25ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	B
The	the	DT	O
enzymatic	enzymatic	JJ	O
reaction	reaction	NN	O
contained	contain	VBD	O
1.4âml	1.4âml	CD	O
0.05âM	0.05âm	IN	O
Tris	Tris	NNP	O
-	-	HYPH	O
SO4	SO4	NNP	O
buffer	buffer	NN	O
,	,	,	O
1âml	1âml	CD	O
3âmM	3âmm	CD	O
4-nitrophenylacetate	4-nitrophenylacetate	CD	O
,	,	,	O
0.5âml	0.5âml	NNP	O
H2O	H2O	NNP	O
and	and	CC	O
0.1âml	0.1âml	NNP	O
enzyme	enzyme	NNS	O
solution	solution	NN	O
,	,	,	O
in	in	IN	O
a	a	DT	O
total	total	JJ	O
volume	volume	NN	O
of	of	IN	O
3.0âml	3.0âml	CD	O
.	.	.	B
Inhibitory	Inhibitory	NNP	O
effects	effect	NNS	O
of	of	IN	O
compounds	compound	NNS	O
1â10	1â10	CD	O
were	be	VBD	O
compared	compare	VBN	O
with	with	IN	O
acetazolamide	acetazolamide	NN	O
.	.	.	O

Different	different	JJ	O
inhibitor	inhibitor	NN	O
concentrations	concentration	NNS	O
were	be	VBD	O
used	use	VBN	O
and	and	CC	O
all	all	DT	O
compounds	compound	NNS	O
were	be	VBD	O
tested	test	VBN	O
in	in	IN	O
triplicate	triplicate	NN	O
at	at	IN	O
each	each	DT	O
concentration	concentration	NN	O
used	use	VBN	O
.	.	.	O

Control	control	NN	O
cuvette	cuvette	NN	O
activity	activity	NN	O
was	be	VBD	O
acknowledged	acknowledge	VBN	O
as	as	IN	O
100	100	CD	O
%	%	NN	O
in	in	IN	O
the	the	DT	O
absence	absence	NN	O
of	of	IN	O
inhibitor	inhibitor	NN	O
.	.	.	O

An	an	DT	O
Activity%	activity%	NN	O
â	â	NNP	O
graph	graph	NN	O
was	be	VBD	O
drawn	draw	VBN	O
for	for	IN	O
each	each	DT	O
inhibitor	inhibitor	NN	O
.	.	.	B
The	the	DT	O
curve	curve	NN	O
-	-	HYPH	O
fitting	fit	VBG	O
algorithm	algorithm	NN	O
allowed	allow	VBN	O
for	for	IN	O
obtaining	obtain	VBG	O
the	the	DT	O
IC50	IC50	NNP	O
values	value	NNS	O
,	,	,	O
working	work	VBG	O
at	at	IN	O
the	the	DT	O
lowest	low	JJS	O
concentration	concentration	NN	O
of	of	IN	O
substrate	substrate	NN	O
of	of	IN	O
0.15âmM	0.15âmm	NN	O
,	,	,	O
from	from	IN	O
which	which	WDT	O
Ki	Ki	NNP	O
values	value	NNS	O
were	be	VBD	O
calculated	calculate	VBN	O
.	.	.	B
,	,	,	B
The	the	DT	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
of	of	IN	O
these	these	DT	O
enzymes	enzyme	NNS	O
was	be	VBD	O
calculated	calculate	VBN	O
from	from	IN	O
Lineweaver	Lineweaver	NNP	O
-	-	HYPH	O
Burk	Burk	NNP	O
plots	plot	NNS	O
,	,	,	O
as	as	IN	O
reported	report	VBN	O
previously	previously	RB	O
,	,	,	O
and	and	CC	O
represent	represent	VB	O
the	the	DT	O
mean	mean	NN	O
from	from	IN	O
at	at	RB	O
least	least	RBS	O
three	three	CD	O
different	different	JJ	O
determinations	determination	NNS	O
.	.	.	O

The	the	DT	O
hCA	hca	NN	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
isoenzymes	isoenzyme	NNS	O
used	use	VBN	O
here	here	RB	O
were	be	VBD	O
purified	purify	VBN	O
from	from	IN	O
human	human	JJ	O
blood	blood	NN	O
as	as	IN	O
previously	previously	RB	O
described	describe	VBN	O
.	.	.	O

CYTOWANIEAs	cytowanieas	VB	O
a	a	DT	O
crucial	crucial	JJ	O
step	step	NN	O
to	to	TO	O
meet	meet	VB	O
minimum	minimum	JJ	O
requirements	requirement	NNS	O
for	for	IN	O
further	further	JJ	O
computational	computational	JJ	O
calculations	calculation	NNS	O
,	,	,	O
all	all	PDT	O
the	the	DT	O
studied	study	VBN	O
ligands	ligand	NNS	O
and	and	CC	O
target	target	NN	O
proteins	protein	NNS	O
were	be	VBD	O
prepared	prepare	VBN	O
.	.	.	O

LigPrep	LigPrep	NNP	O
tool	tool	NN	B
interfaced	interface	VBN	O
with	with	IN	O
Maestro	Maestro	NNP	O
module	module	NN	O
of	of	IN	O
SchrÃ¶dinger	SchrÃ¶dinger	NNP	B
suite	suite	NN	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
the	the	DT	O
ligand	ligand	NN	O
preparation	preparation	NN	O
.	.	.	O

The	the	DT	O
3âD	3âd	JJ	O
structures	structure	NNS	O
including	include	VBG	O
all	all	DT	O
possible	possible	JJ	O
tautomers	tautomer	NNS	O
and	and	CC	O
ionisation	ionisation	NN	O
states	state	NNS	O
at	at	IN	O
pH	pH	NNP	O
7.0âÂ±â2.0	7.0ââ±â2.0	CD	O
of	of	IN	O
all	all	PDT	O
the	the	DT	O
ligands	ligands	NNP	O
1â10	1â10	CD	O
and	and	CC	O
the	the	DT	O
reference	reference	NN	O
compound	compound	NN	O
AZA	AZA	NNP	O
were	be	VBD	O
generated	generate	VBN	O
and	and	CC	O
geometrically	geometrically	RB	O
minimised	minimise	VBN	O
using	use	VBG	O
optimised	optimise	VBN	O
potential	potential	JJ	O
liquid	liquid	JJ	O
simulations	simulation	NNS	O
force	force	NNP	O
field	field	NN	O
.	.	.	O

CYTOWANIESchrÃ¶dingerâs	CYTOWANIESchrÃ¶dingerâs	NNP	O
multi	multi	JJ	O
-	-	JJ	O
step	step	NN	O
Protein	Protein	NNP	O
Preparation	Preparation	NNP	O
Wizard	Wizard	NNP	O
PrepWizard	PrepWizard	NNP	O
)	)	-RRB-	B
were	be	VBD	O
used	use	VBN	O
for	for	IN	O
the	the	DT	O
protein	protein	NN	O
preparations	preparation	NNS	O
.	.	.	O

As	as	IN	O
an	an	DT	O
initial	initial	JJ	O
step	step	NN	O
,	,	,	O
high	high	JJ	O
-	-	HYPH	O
resolution	resolution	NN	O
protein	protein	NN	O
crystal	crystal	NN	O
structures	structure	NNS	O
of	of	IN	O
CA	CA	NNP	O
I	I	NNP	O
and	and	CC	O
II	II	NNP	O
,	,	,	O
both	both	CC	O
in	in	IN	O
complexed	complexe	VBN	O
with	with	IN	O
a	a	DT	O
native	native	JJ	O
ligand	ligand	NN	O
,	,	,	O
were	be	VBD	O
retrieved	retrieve	VBN	O
from	from	IN	O
RCSB	RCSB	NNP	O
Protein	Protein	NNP	O
Data	Data	NNPS	O
Bank	Bank	NNP	O
.	.	.	O

Charges	charge	NNS	O
and	and	CC	O
bond	bond	NN	O
orders	order	NNS	O
were	be	VBD	O
assigned	assign	VBN	O
,	,	,	O
hydrogens	hydrogen	NNS	O
were	be	VBD	O
added	add	VBN	O
to	to	IN	O
the	the	DT	O
heavy	heavy	JJ	O
atoms	atom	NNS	O
,	,	,	O
all	all	DT	O
water	water	NN	O
molecules	molecule	NNS	O
and	and	CC	O
heteroatoms	heteroatom	NNS	O
were	be	VBD	O
then	then	RB	O
removed	remove	VBN	O
keeping	keep	VBG	O
the	the	DT	O
native	native	JJ	O
ligands	ligand	NNS	O
and	and	CC	O
zinc	zinc	NN	O
metals	metal	NNS	O
in	in	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

The	the	DT	O
final	final	JJ	O
structures	structure	NNS	O
were	be	VBD	O
optimised	optimise	VBN	O
and	and	CC	O
finally	finally	RB	O
minimised	minimise	VBN	O
using	use	VBG	O
OPLS3	OPLS3	NNP	O
force	force	NNP	O
field	field	NN	O
to	to	TO	O
avoid	avoid	VB	O
steric	steric	JJ	O
clashes	clash	NNS	O
between	between	IN	O
the	the	DT	O
atoms	atom	NNS	O
.	.	.	O

A	a	DT	O
grid	grid	NN	O
representing	represent	VBG	O
the	the	DT	O
binding	bind	VBG	O
pocket	pocket	NN	O
was	be	VBD	O
generated	generate	VBN	O
using	use	VBG	O
the	the	DT	O
centroid	centroid	NN	O
of	of	IN	O
co	co	JJ	O
-	-	JJ	O
crystallized	crystallized	JJ	O
native	native	JJ	O
ligands	ligand	NNS	O
.	.	.	O

Default	default	NN	O
settings	setting	NNS	O
were	be	VBD	O
kept	keep	VBN	O
in	in	IN	O
each	each	DT	O
case	case	NN	O
.	.	.	O

Glide	Glide	NNP	O
XP	XP	NNP	B
module	module	NN	O
of	of	IN	O
SchrÃ¶dinger	SchrÃ¶dinger	NNP	O
Suite	Suite	NNP	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
dock	dock	VB	O
the	the	DT	O
synthesised	synthesise	VBN	O
compounds	compound	NNS	O
into	into	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
the	the	DT	O
crystal	crystal	NN	O
structures	structure	NNS	O
.	.	.	O

The	the	DT	O
rescoring	rescoring	NN	O
was	be	VBD	O
performed	perform	VBN	O
to	to	TO	O
calculate	calculate	VB	O
and	and	CC	O
improved	improve	VBN	O
binding	bind	VBG	O
energy	energy	NN	O
calculations	calculation	NNS	O
with	with	IN	O
Primeâs	primeâs	CD	O
Molecular	Molecular	NNP	O
MechanicsâGeneralized	mechanicsâgeneralize	VBN	O
Born	Born	NNP	O
Surface	Surface	NNP	O
Area	Area	NNP	O
MMâGBSA	mmâgbsa	NN	O
protocol	protocol	NN	O
using	use	VBG	O
VSGB	VSGB	NNP	O
solvation	solvation	NN	O
model	model	NN	O
.	.	.	B
,	,	,	O
CYTOWANIEQikProp	CYTOWANIEQikProp	NNP	B
module	module	NN	O
of	of	IN	O
Schrodinger	Schrodinger	NNP	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
calculate	calculate	VB	O
some	some	DT	O
commonly	commonly	RB	O
used	use	VBN	O
molecular	molecular	JJ	O
descriptors	descriptor	NNS	O
such	such	JJ	O
as	as	IN	O
dipole	dipole	JJ	O
moment	moment	NN	O
,	,	,	O
logarithm	logarithm	NNP	O
of	of	IN	O
octanol	octanol	NN	O
-	-	HYPH	O
water	water	NN	O
partition	partition	NN	O
coefficient	coefficient	NN	O
,	,	,	O
percent	percent	NN	O
human	human	JJ	O
oral	oral	JJ	O
absorption	absorption	NN	O
,	,	,	O
polar	polar	JJ	O
surface	surface	NN	O
area	area	NN	O
and	and	CC	O
violations	violation	NNS	O
to	to	IN	O
the	the	DT	O
Lipinskiâs	Lipinskiâs	NNP	O
rule	rule	NN	O
of	of	IN	O
five	five	CD	O
.	.	.	O

CYTOWANIEThe	cytowaniethe	IN	O
new	new	JJ	O
4,5-dihydro-1H	4,5-dihydro-1h	CD	O
-	-	HYPH	O
pyrazole-1-carbothioamide	pyrazole-1-carbothioamide	JJ	O
derivatives	derivative	NNS	O
6â10	6â10	CD	O
were	be	VBD	O
prepared	prepare	VBN	O
from	from	IN	O
the	the	DT	O
chalcones	chalcone	NNS	O
1and	1and	CD	O
5	5	CD	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
reactions	reaction	NNS	O
outlined	outline	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
1	1	CD	O
.	.	.	O

Initially	initially	RB	O
,	,	,	O
chalcones	chalcone	NNS	O
1â5	1â5	NN	O
were	be	VBD	O
prepared	prepare	VBN	O
through	through	IN	O
Claisen	Claisen	NNP	O
-	-	HYPH	O
Schmidt	Schmidt	NNP	O
condensation	condensation	NN	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
the	the	DT	O
most	most	RBS	O
important	important	JJ	O
reaction	reaction	NN	O
in	in	IN	O
the	the	DT	O
formation	formation	NN	O
of	of	IN	O
1,3-diphenyl-2-propene-1-ones	1,3-diphenyl-2-propene-1-ones	CD	O
,	,	,	O
of	of	IN	O
various	various	JJ	O
benzaldehydes	benzaldehyde	NNS	O
with	with	IN	O
4-amino	4-amino	CD	O
,	,	,	O
bromo	bromo	NN	O
,	,	,	O
methyl	methyl	NN	O
and	and	CC	O
hydroxyl	hydroxyl	NN	O
acetophenones	acetophenone	NNS	O
.	.	.	O

The	the	DT	O
reaction	reaction	NN	O
was	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
in	in	IN	O
60	60	CD	O
%	%	NN	O
sodium	sodium	NN	O
hydroxide	hydroxide	NN	O
:	:	:	O
ethanol	ethanol	NN	O
for	for	IN	O
24âh	24âh	CD	O
as	as	RB	O
stated	state	VBN	O
in	in	IN	O
previous	previous	JJ	O
works	work	NNS	O
.	.	.	B
Then	then	RB	O
,	,	,	O
new	new	JJ	O
1-thiocarbamoyl-3,5-diaryl-4,5-dihydro	1-thiocarbamoyl-3,5-diaryl-4,5-dihydro	CD	O
--	--	:	O
pyrazole	pyrazole	NN	O
derivatives	derivative	NNS	O
6â10	6â10	CD	O
were	be	VBD	O
obtained	obtain	VBN	O
by	by	IN	O
cyclisation	cyclisation	NN	O
of	of	IN	O
chalcones	chalcone	NNS	O
1â5	1â5	NN	O
with	with	IN	O
two	two	CD	O
equivalents	equivalent	NNS	O
of	of	IN	O
thiosemicarbazide	thiosemicarbazide	NN	O
with	with	IN	O
sodium	sodium	NN	O
hydroxide	hydroxide	NN	O
presence	presence	NN	O
in	in	IN	O
ethanol	ethanol	NN	O
.	.	.	O

Compound	Compound	NNP	O
7â9	7â9	NNP	O
was	be	VBD	O
reported	report	VBN	O
in	in	IN	O
a	a	DT	O
previous	previous	JJ	O
study	study	NN	O
.	.	.	B
The	the	DT	O
synthesis	synthesis	NN	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
6	6	CD	O
,	,	,	O
8	8	CD	O
and	and	CC	O
10	10	CD	O
is	be	VBZ	O
being	be	VBG	O
reported	report	VBN	O
for	for	IN	O
the	the	DT	O
first	first	JJ	O
time	time	NN	O
in	in	IN	O
this	this	DT	O
work	work	NN	O
.	.	.	O

At	at	IN	O
the	the	DT	O
end	end	NN	O
of	of	IN	O
the	the	DT	O
synthesis	synthesis	NN	O
,	,	,	O
the	the	DT	O
crude	crude	JJ	O
product	product	NN	O
was	be	VBD	O
purified	purify	VBN	O
by	by	IN	O
recrystallization	recrystallization	NN	O
two	two	CD	O
times	time	NNS	O
from	from	IN	O
EtOH	EtOH	NNP	O
:	:	:	O
H2O	h2o	NN	O
to	to	TO	O
obtain	obtain	VB	O
yellow	yellow	JJ	O
crystals	crystal	NNS	O
.	.	.	O

The	the	DT	O
structures	structure	NNS	O
of	of	IN	O
all	all	PDT	O
the	the	DT	O
compounds	compound	NNS	O
were	be	VBD	O
confirmed	confirm	VBN	O
by	by	IN	O
spectral	spectral	JJ	O
FT	FT	NNP	O
-	-	HYPH	O
IR	IR	NNP	O
,	,	,	O
1H	1H	NNP	O
and	and	CC	O
13âC	13âc	JJ	O
NMR	NMR	NNP	O
and	and	CC	O
elemental	elemental	JJ	O
analyses	analysis	NNS	O
.	.	.	O

1H	1H	NNP	O
NMR	NMR	NNP	O
spectra	spectra	NN	O
of	of	IN	O
the	the	DT	O
title	title	NN	O
compounds	compound	NNS	O
were	be	VBD	O
consistent	consistent	JJ	O
with	with	IN	O
expected	expect	VBN	O
resonance	resonance	NN	O
signals	signal	NNS	O
in	in	IN	O
terms	term	NNS	O
of	of	IN	O
chemical	chemical	NN	O
shifts	shift	NNS	O
and	and	CC	O
integrations	integration	NNS	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
13âC	13âc	JJ	O
NMR	NMR	NNP	O
findings	finding	NNS	O
confirmed	confirm	VBD	O
the	the	DT	O
structures	structure	NNS	O
proposed	propose	VBN	O
.	.	.	O

Selected	select	VBN	O
13âC	13âC	NNP	O
NMR	NMR	NNP	O
spectrum	spectrum	NN	O
are	be	VBP	O
given	give	VBN	O
in	in	IN	O
Figure	figure	NN	O
2.60	2.60	CD	O
%	%	NN	O
Aq	Aq	NNP	O
NaOH	NaOH	NNP	O
,	,	,	O
EtOH	EtOH	NNP	O
,	,	,	O
24âh	24âh	CD	O
;	;	:	O
Thiosemicarbazide	Thiosemicarbazide	NNP	O
,	,	,	O
KOH	KOH	NNP	O
,	,	,	O
EtOH	EtOH	NNP	O
,	,	,	O
reflux	reflux	NNP	O
18âh.13âC	18âh.13âC	NNP	O
NMR	NMR	NNP	O
spectrum	spectrum	NN	O
of	of	IN	O
compound	compound	NNP	O
6	6	CD	O
.	.	.	O

The	the	DT	O
inhibitory	inhibitory	JJ	O
effects	effect	NNS	O
of	of	IN	O
all	all	PDT	O
the	the	DT	O
synthesised	synthesise	VBN	O
compounds	compound	NNS	O
were	be	VBD	O
investigated	investigate	VBN	O
for	for	IN	O
the	the	DT	O
first	first	JJ	O
time	time	NN	O
against	against	IN	O
hCA	hCA	NNP	O
isozymes	isozyme	NNS	O
:	:	:	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
and	and	CC	O
hCA	hCA	VBD	O
II	II	NNP	O
.	.	.	O

Human	Human	NNP	O
CA	CA	NNP	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
isozymes	isozyme	NNS	O
were	be	VBD	O
purified	purify	VBN	O
by	by	IN	O
one	one	CD	O
step	step	NN	O
chromatography	chromatography	NN	O
technique	technique	NN	O
and	and	CC	O
the	the	DT	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
effluents	effluent	NNS	O
was	be	VBD	O
determined	determine	VBN	O
by	by	IN	O
the	the	DT	O
hydratase	hydratase	NN	O
method	method	NN	O
,	,	,	O
using	use	VBG	O
CO2	CO2	NNP	O
as	as	IN	O
substrate	substrate	NN	O
and	and	CC	O
further	further	JJ	O
kinetic	kinetic	JJ	O
studies	study	NNS	O
were	be	VBD	O
performed	perform	VBN	O
using	use	VBG	O
the	the	DT	O
esterase	esterase	NN	O
activity	activity	NN	O
method	method	NN	O
,	,	,	O
using	use	VBG	O
4-nitrophenyl	4-nitrophenyl	CD	O
acetate	acetate	RB	O
as	as	IN	O
substrate	substrate	NN	O
.	.	.	B
Inhibition	inhibition	NN	O
characteristics	characteristic	NNS	O
of	of	IN	O
five	five	CD	O
pyrazoles	pyrazole	NNS	O
,	,	,	O
five	five	CD	O
chalcones	chalcone	NNS	O
and	and	CC	O
various	various	JJ	O
reference	reference	NN	O
compounds	compound	NNS	O
are	be	VBP	O
given	give	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
clear	clear	JJ	O
from	from	IN	O
the	the	DT	O
results	result	NNS	O
that	that	WDT	O
all	all	DT	O
molecules	molecule	NNS	O
were	be	VBD	O
found	find	VBN	O
to	to	TO	O
act	act	VB	O
as	as	RB	O
low	low	JJ	O
-	-	HYPH	O
nanomolar	nanomolar	NN	O
hCA	hca	NN	O
I	I	NNP	O
-	-	HYPH	O
II	II	NNP	O
inhibitors	inhibitor	NNS	O
.	.	.	O

According	accord	VBG	O
to	to	IN	O
the	the	DT	O
experimental	experimental	JJ	O
findings	finding	NNS	O
,	,	,	O
all	all	DT	O
chalcone	chalcone	NN	O
and	and	CC	O
new	new	JJ	O
pyrazole	pyrazole	NN	O
compounds	compound	NNS	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
had	have	VBD	O
better	well	JJR	O
inhibition	inhibition	NN	O
constants	constant	NNS	O
than	than	IN	O
the	the	DT	O
clinically	clinically	RB	O
used	use	VBN	O
inhibitor	inhibitor	NN	O
acetazolamide	acetazolamide	NN	O
and	and	CC	O
other	other	JJ	O
widely	widely	RB	O
used	use	VBN	O
inhibitors	inhibitor	NNS	O
and	and	CC	O
also	also	RB	O
comparable	comparable	JJ	O
IC50	IC50	NNP	O
values	value	NNS	O
with	with	IN	O
AZA	AZA	NNP	O
.	.	.	O

However	however	RB	O
,	,	,	O
they	-PRON-	PRP	O
possessed	possess	VBD	O
different	different	JJ	O
selectivity	selectivity	NN	O
against	against	IN	O
hCAI	hCAI	NNP	O
-	-	HYPH	O
II	II	NNP	O
.	.	.	O

The	the	DT	O
new	new	JJ	O
compounds	compound	NNS	O
6	6	CD	O
and	and	CC	O
10	10	CD	O
with	with	IN	O
the	the	DT	O
IC50	IC50	NNP	O
values	value	NNS	O
ranging	range	VBG	O
between	between	IN	O
23.87	23.87	CD	O
and	and	CC	O
24.37ânM	24.37ânm	CD	O
showed	show	VBD	O
promising	promise	VBG	O
powerful	powerful	JJ	O
inhibitory	inhibitory	JJ	O
profiles	profile	NNS	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
standard	standard	JJ	O
drug	drug	NN	O
AZA	AZA	NNP	O
and	and	CC	O
they	-PRON-	PRP	O
all	all	DT	O
had	have	VBD	O
comparable	comparable	JJ	O
IC50	IC50	NNP	O
values	value	NNS	O
against	against	IN	O
hCA	hca	XX	O
I.	I.	NNP	O
The	the	DT	O
amino	amino	NN	O
or	or	CC	O
hydroxyl	hydroxyl	NN	O
substituents	substituent	NNS	O
on	on	IN	O
phenyl	phenyl	NN	O
ring	ring	NN	O
could	could	MD	O
easily	easily	RB	O
be	be	VB	O
predicted	predict	VBN	O
to	to	TO	O
be	be	VB	O
involved	involve	VBN	O
in	in	IN	O
making	make	VBG	O
hydrogen	hydrogen	NN	O
bonds	bond	NNS	O
with	with	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
as	as	IN	O
observed	observe	VBN	O
in	in	IN	O
classical	classical	JJ	O
hCA	hCA	NNS	O
I	-PRON-	PRP	O
sulphonamide	sulphonamide	VBP	O
inhibitors	inhibitor	NNS	O
.	.	.	O

Changing	change	VBG	O
the	the	DT	O
hydrophilic	hydrophilic	JJ	O
substituents	substituent	NNS	O
,	,	,	O
âNH2	ânh2	CD	O
or	or	CC	O
âOH	âOH	NNS	O
with	with	IN	O
hydrophilic	hydrophilic	JJ	O
substituents	substituent	NNS	O
,	,	,	O
âBr	âBr	NNP	O
or	or	CC	O
âCH3	âCH3	NNP	O
on	on	IN	O
ring	re	VBG	O
A	a	NN	O
,	,	,	O
have	have	VBP	O
negligible	negligible	JJ	O
effect	effect	NN	O
on	on	IN	O
the	the	DT	O
observed	observed	JJ	O
activity	activity	NN	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
clear	clear	JJ	O
that	that	IN	O
the	the	DT	O
lack	lack	NN	O
of	of	IN	O
moieties	moiety	NNS	O
which	which	WDT	O
can	can	MD	O
make	make	VB	O
favourable	favourable	JJ	O
hydrogen	hydrogen	NN	O
bonding	bonding	NN	O
are	be	VBP	O
being	be	VBG	O
compensated	compensate	VBN	O
with	with	IN	O
hydrophobic	hydrophobic	JJ	O
groups	group	NNS	O
that	that	WDT	O
also	also	RB	O
enhance	enhance	VBP	O
affinity	affinity	NN	O
by	by	IN	O
hydrophobic	hydrophobic	JJ	O
interactions	interaction	NNS	O
.	.	.	O

Furthermore	furthermore	RB	O
,	,	,	O
replacing	replace	VBG	O
methoxy	methoxy	JJ	O
substituents	substituent	NNS	O
with	with	IN	O
N	n	NN	O
,	,	,	O
N	n	CD	O
-	-	HYPH	O
dimethylamino	dimethylamino	NN	O
substituent	substituent	NN	O
does	do	VBZ	O
not	not	RB	O
seem	seem	VB	O
to	to	TO	O
have	have	VB	O
much	much	JJ	O
effect	effect	NN	O
on	on	IN	O
the	the	DT	O
activity	activity	NN	O
.	.	.	O

It	-PRON-	PRP	O
can	can	MD	O
be	be	VB	O
concluded	conclude	VBN	O
that	that	IN	O
methyl	methyl	NN	O
groups	group	NNS	O
in	in	IN	O
both	both	DT	O
cases	case	NNS	O
have	have	VBP	O
favourable	favourable	JJ	O
contacts	contact	NNS	O
with	with	IN	O
hydrophobic	hydrophobic	JJ	O
sites	site	NNS	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
region	region	NN	O
.	.	.	O

Oxygen	oxygen	NN	O
atoms	atom	NNS	O
in	in	IN	O
metoxy	metoxy	JJ	O
groups	group	NNS	O
could	could	MD	O
have	have	VB	O
extra	extra	JJ	O
interactions	interaction	NNS	O
with	with	IN	O
the	the	DT	O
hydrophilic	hydrophilic	JJ	O
regions	region	NNS	O
.	.	.	O

However	however	RB	O
,	,	,	O
methoxy	methoxy	JJ	O
substituents	substituent	NNS	O
on	on	IN	O
ring	ring	NN	O
B	b	NN	O
have	have	VB	O
large	large	JJ	O
impact	impact	NN	O
on	on	IN	O
the	the	DT	O
activity	activity	NN	O
towards	towards	IN	O
hCA	hca	CD	O
II	II	NNP	O
.	.	.	O

The	the	DT	O
IC50	IC50	NNP	O
value	value	NN	O
diminishes	diminish	VBZ	O
more	more	JJR	O
than	than	IN	O
two	two	CD	O
-	-	HYPH	O
folds	fold	NNS	O
when	when	WRB	O
trimethoxy	trimethoxy	NN	O
phenyl	phenyl	NNP	O
is	be	VBZ	O
being	be	VBG	O
replaced	replace	VBN	O
with	with	IN	O
N	n	NN	O
,	,	,	O
N	N	NNP	O
-	-	HYPH	O
dimethy	dimethy	NN	O
aniline	aniline	NN	O
which	which	WDT	O
results	result	VBZ	O
in	in	IN	O
a	a	DT	O
promising	promising	JJ	O
selectivity	selectivity	NN	O
profile	profile	NN	O
for	for	IN	O
this	this	DT	O
compound	compound	NN	O
.	.	.	O

As	as	IN	O
a	a	DT	O
result	result	NN	O
of	of	IN	O
those	those	DT	O
observations	observation	NNS	O
,	,	,	O
we	-PRON-	PRP	O
found	find	VBD	O
it	-PRON-	PRP	O
necessary	necessary	JJ	O
to	to	TO	O
carry	carry	VB	O
out	out	RP	O
in	in	IN	O
silico	silico	NN	O
studies	study	NNS	O
.	.	.	O

The	the	DT	O
data	datum	NNS	O
of	of	IN	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
and	and	CC	O
II	ii	CD	O
inhibition	inhibition	NN	O
with	with	IN	O
compounds	compound	NNS	O
1â10	1â10	CD	O
and	and	CC	O
AZA.aMean	AZA.aMean	NNP	O
from	from	IN	O
at	at	RB	O
least	least	RBS	O
three	three	CD	O
determinations	determination	NNS	O
.	.	.	O

Errors	error	NNS	O
in	in	IN	O
the	the	DT	O
range	range	NN	O
of	of	IN	O
3	3	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
reported	report	VBN	O
value	value	NN	O
.	.	.	O

bFrom	bFrom	NNP	O
Ref	Ref	NNP	O
.	.	.	B
.	.	.	O

The	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
both	both	DT	O
hCAI	hcai	NN	O
and	and	CC	O
II	II	NNP	O
,	,	,	O
as	as	IN	O
in	in	IN	O
all	all	DT	O
other	other	JJ	O
CAs	ca	NNS	O
,	,	,	O
is	be	VBZ	O
lined	line	VBN	O
with	with	IN	O
both	both	CC	O
hydrophobic	hydrophobic	NN	O
and	and	CC	O
hydrophilic	hydrophilic	JJ	O
residues	residue	NNS	O
.	.	.	O

Hydrophobic	hydrophobic	JJ	O
part	part	NN	O
is	be	VBZ	O
believed	believe	VBN	O
to	to	TO	O
be	be	VB	O
responsible	responsible	JJ	O
for	for	IN	O
entrapping	entrap	VBG	O
the	the	DT	O
lipophilic	lipophilic	JJ	O
CO2	CO2	NNP	O
molecule	molecule	VBP	O
,	,	,	O
and	and	CC	O
the	the	DT	O
other	other	JJ	O
the	the	DT	O
part	part	NN	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
helps	help	VBZ	O
releasing	release	VBG	O
the	the	DT	O
polar	polar	JJ	O
components	component	NNS	O
after	after	IN	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
reaction	reaction	NN	O
to	to	IN	O
the	the	DT	O
environment	environment	NN	O
.	.	.	B
All	all	PDT	O
the	the	DT	O
synthesised	synthesise	VBN	O
new	new	JJ	O
compounds	compound	NNS	O
were	be	VBD	O
found	find	VBN	O
to	to	TO	O
have	have	VB	O
low	low	JJ	O
IC50	IC50	NNP	O
values	value	NNS	O
in	in	IN	O
the	the	DT	O
low	low	JJ	O
nanomolar	nanomolar	JJ	O
range	range	NN	O
.	.	.	O

Although	although	IN	O
it	-PRON-	PRP	O
is	be	VBZ	O
well	well	RB	O
known	know	VBN	O
that	that	IN	O
the	the	DT	O
commonly	commonly	RB	O
used	use	VBN	O
docking	dock	VBG	O
software	software	NN	O
available	available	JJ	O
at	at	IN	O
the	the	DT	O
market	market	NN	O
performs	perform	VBZ	O
well	well	RB	O
in	in	IN	O
predicting	predict	VBG	O
the	the	DT	O
active	active	JJ	O
conformations	conformation	NNS	O
of	of	IN	O
the	the	DT	O
biologically	biologically	RB	O
active	active	JJ	O
compounds	compound	NNS	O
but	but	CC	O
the	the	DT	O
present	present	JJ	O
scoring	scoring	NN	O
functions	function	NNS	O
are	be	VBP	O
not	not	RB	O
expected	expect	VBN	O
to	to	TO	O
discriminate	discriminate	VB	O
between	between	IN	O
active	active	JJ	O
and	and	CC	O
inactive	inactive	JJ	O
compounds	compound	NNS	O
.	.	.	B
We	-PRON-	PRP	O
have	have	VBP	O
obtained	obtain	VBN	O
satisfying	satisfying	JJ	O
results	result	NNS	O
using	use	VBG	O
Glide	Glide	NNP	O
in	in	IN	O
our	-PRON-	PRP$	O
recent	recent	JJ	O
studies	study	NNS	O
.	.	.	B
In	in	IN	O
the	the	DT	O
current	current	JJ	O
study	study	NN	O
,	,	,	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
improve	improve	VB	O
the	the	DT	O
docking	docking	NN	O
scores	score	NNS	O
,	,	,	O
we	-PRON-	PRP	O
performed	perform	VBD	O
more	more	RBR	O
rigorous	rigorous	JJ	O
binding	bind	VBG	O
energy	energy	NN	O
calculations	calculation	NNS	O
using	use	VBG	O
MM	MM	NNP	O
-	-	HYPH	O
GBSA	GBSA	NNP	O
protocol	protocol	NN	O
.	.	.	O

We	-PRON-	PRP	O
have	have	VBP	O
let	let	VBN	O
the	the	DT	O
residues	residue	NNS	O
in	in	IN	O
3âÃ	3âã	CD	O
distance	distance	NN	O
from	from	IN	O
the	the	DT	O
ligands	ligand	NNS	O
to	to	TO	O
be	be	VB	O
relaxed	relax	VBN	O
during	during	IN	O
the	the	DT	O
computations	computation	NNS	O
.	.	.	O

MM	MM	NNP	O
-	-	HYPH	O
GBSA	GBSA	NNP	O
ÎGbinding	îgbinde	VBG	O
values	value	NNS	O
substantially	substantially	RB	O
agreed	agree	VBD	O
well	well	RB	O
with	with	IN	O
the	the	DT	O
experimental	experimental	JJ	O
inhibition	inhibition	NN	O
data	datum	NNS	O
.	.	.	O

According	accord	VBG	O
to	to	IN	O
the	the	DT	O
MM	MM	NNP	O
-	-	HYPH	O
GBSA	GBSA	NNP	O
calculations	calculation	NNS	O
,	,	,	O
compound	compound	VB	O
6	6	CD	O
scored	score	VBD	O
top	top	NN	O
in	in	IN	O
both	both	DT	O
hCA	hca	CD	O
isoforms	isoform	NNS	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
noteworthy	noteworthy	JJ	O
to	to	TO	O
mention	mention	VB	O
that	that	IN	O
,	,	,	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
IC50	IC50	NNP	O
results	result	NNS	O
listed	list	VBN	O
in	in	IN	O
Table	table	NN	O
2	2	CD	O
,	,	,	O
the	the	DT	O
compound	compound	NN	O
10	10	CD	O
showed	show	VBD	O
a	a	DT	O
slight	slight	JJ	O
hCA	hca	NN	O
I	-PRON-	PRP	O
versus	versus	IN	O
hCA	hca	CD	O
II	ii	CD	O
selectivity	selectivity	NN	O
,	,	,	O
with	with	IN	O
a	a	DT	O
selectivity	selectivity	NN	O
ratio	ratio	NN	O
of	of	IN	O
3.46	3.46	CD	O
.	.	.	O

The	the	DT	O
2âD	2âd	CD	O
and	and	CC	O
3âD	3âd	CD	O
ligand	ligand	NNP	O
interaction	interaction	NN	O
diagrams	diagram	NNS	O
of	of	IN	O
both	both	DT	O
compounds	compound	NNS	O
with	with	IN	O
the	the	DT	O
hCA	hca	NN	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
isoforms	isoform	NNS	O
are	be	VBP	O
shown	show	VBN	O
in	in	IN	O
Figures	Figures	NNP	O
4	4	CD	O
and	and	CC	O
5	5	CD	O
.	.	.	O

Compound	Compound	NNP	O
6	6	CD	O
binds	bind	NNS	O
in	in	IN	O
a	a	DT	O
rather	rather	RB	O
similar	similar	JJ	O
manner	manner	NN	O
with	with	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
both	both	DT	O
isoforms	isoform	NNS	O
.	.	.	O

The	the	DT	O
amino	amino	JJ	O
group	group	NN	O
of	of	IN	O
aniline	aniline	NN	O
part	part	NN	O
acts	act	VBZ	O
as	as	IN	O
a	a	DT	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
donor	donor	NN	O
and	and	CC	O
interacts	interact	VBZ	O
with	with	IN	O
the	the	DT	O
TYR199	TYR199	NNP	O
residue	residue	NN	O
while	while	IN	O
the	the	DT	O
aromatic	aromatic	JJ	O
part	part	NN	O
establishes	establish	VBZ	O
a	a	DT	O
Ï-Ï	Ï-Ï	NNP	O
interaction	interaction	NN	O
with	with	IN	O
the	the	DT	O
residue	residue	NN	O
HIS94	HIS94	NNP	O
.	.	.	O

It	-PRON-	PRP	O
also	also	RB	O
has	have	VBZ	O
favourable	favourable	JJ	O
interactions	interaction	NNS	O
with	with	IN	O
the	the	DT	O
polar	polar	JJ	O
residues	residue	NNS	O
at	at	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
entrance	entrance	NN	O
.	.	.	O

Compound	Compound	NNP	O
10	10	CD	O
has	have	VBZ	O
same	same	JJ	O
type	type	NN	O
of	of	IN	O
interactions	interaction	NNS	O
with	with	IN	O
the	the	DT	O
critical	critical	JJ	O
residues	residue	NNS	O
at	at	IN	O
the	the	DT	O
binding	bind	VBG	O
site	site	NN	O
of	of	IN	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
:	:	:	O
phenolic	phenolic	NNP	O
-OH	-OH	NNP	O
group	group	NNP	O
participates	participate	VBZ	O
in	in	IN	O
hydrogen	hydrogen	NN	O
bonding	bonding	NN	O
with	with	IN	O
THR199	THR199	NNP	O
and	and	CC	O
the	the	DT	O
same	same	JJ	O
Ï-Ï	Ï-Ï	NNP	O
interaction	interaction	NN	O
of	of	IN	O
the	the	DT	O
aromatic	aromatic	JJ	O
ring	ring	NN	O
with	with	IN	O
the	the	DT	O
residue	residue	NN	O
HIS94	HIS94	NNP	O
is	be	VBZ	O
observed	observe	VBN	O
.	.	.	O

Interestingly	interestingly	RB	O
,	,	,	O
the	the	DT	O
orientation	orientation	NN	O
is	be	VBZ	O
inverted	invert	VBN	O
in	in	IN	O
the	the	DT	O
active	active	JJ	O
region	region	NN	O
of	of	IN	O
hCA	hca	CD	O
II	II	NNP	O
.	.	.	O

The	the	DT	O
N	N	NNP	O
,	,	,	O
N	N	NNP	O
-	-	HYPH	O
dimethyl	dimethyl	NN	O
aniline	aniline	NN	O
moiety	moiety	NN	O
is	be	VBZ	O
buried	bury	VBN	O
deep	deep	RB	O
in	in	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
whereas	whereas	IN	O
phenol	phenol	NN	O
interacts	interact	VBZ	O
with	with	IN	O
the	the	DT	O
negatively	negatively	RB	O
charged	charge	VBN	O
residue	residue	NN	O
GLU69	GLU69	NNP	O
.	.	.	O

The	the	DT	O
lack	lack	NN	O
of	of	IN	O
contacts	contact	NNS	O
with	with	IN	O
the	the	DT	O
key	key	JJ	O
residues	residue	NNS	O
HIS	HIS	NNP	O
94	94	CD	O
and	and	CC	O
THR	THR	NNP	O
199	199	CD	O
could	could	MD	O
be	be	VB	O
responsible	responsible	JJ	O
for	for	IN	O
the	the	DT	O
decreased	decreased	JJ	O
activity	activity	NN	O
towards	towards	IN	O
hCA	hca	CD	O
II	II	NNP	O
.	.	.	O

A	a	DT	O
representative	representative	JJ	O
hydrophobic	hydrophobic	NN	O
/	/	SYM	O
philic	philic	JJ	O
surfaces	surface	NNS	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
complexed	complexe	VBD	O
with	with	IN	O
a	a	DT	O
native	native	JJ	O
ligand	ligand	NN	O
.	.	.	O

.	.	.	O

The	the	DT	O
2âD	2âd	CD	O
and	and	CC	O
3âD	3âd	CD	O
ligand	ligand	NNP	O
interaction	interaction	NN	O
diagrams	diagram	NNS	O
of	of	IN	O
hCA	hca	CD	O
I-6	I-6	NNP	O
and	and	CC	O
hCA	hCA	VBZ	O
II-6	ii-6	JJ	O
complexes	complex	NNS	O
obtained	obtain	VBN	O
from	from	IN	O
prime	prime	JJ	O
MM	MM	NNP	O
-	-	HYPH	O
GBSA	GBSA	NNP	O
using	use	VBG	O
Glide	Glide	NNP	O
XP	XP	NNP	O
docked	dock	VBD	O
poses	pose	NNS	O
In	in	IN	O
3âD	3âd	CD	O
representation	representation	NN	O
,	,	,	O
hydrogen	hydrogen	NN	O
bonds	bond	NNS	O
are	be	VBP	O
shown	show	VBN	O
with	with	IN	O
yellow	yellow	JJ	O
dashed	dash	VBN	O
lines	line	NNS	O
,	,	,	O
Ï-Ï	Ï-Ï	NNP	O
interactions	interaction	NNS	O
are	be	VBP	O
shown	show	VBN	O
with	with	IN	O
cyan	cyan	NNP	O
colour	colour	NN	O
.	.	.	O

The	the	DT	O
distance	distance	NN	O
between	between	IN	O
Zinc	Zinc	NNP	O
metal	metal	NN	O
and	and	CC	O
interacting	interact	VBG	O
atom	atom	NN	O
is	be	VBZ	O
shown	show	VBN	O
with	with	IN	O
pink	pink	JJ	O
colour	colour	NN	O
.	.	.	O

The	the	DT	O
2âD	2âd	CD	O
and	and	CC	O
3âD	3âd	CD	O
ligand	ligand	NNP	O
interaction	interaction	NN	O
diagrams	diagram	NNS	O
of	of	IN	O
hCA	hca	CD	O
I-10	i-10	CD	O
and	and	CC	O
hCA	hCA	NNP	O
II-10	II-10	NNP	O
complexes	complex	NNS	O
obtained	obtain	VBN	O
from	from	IN	O
prime	prime	JJ	O
MM	MM	NNP	O
-	-	HYPH	O
GBSA	GBSA	NNP	O
using	use	VBG	O
Glide	Glide	NNP	O
XP	XP	NNP	O
docked	dock	VBD	O
poses	pose	NNS	O
In	in	IN	O
3âD	3âd	CD	O
representation	representation	NN	O
,	,	,	O
hydrogen	hydrogen	NN	O
bonds	bond	NNS	O
are	be	VBP	O
shown	show	VBN	O
with	with	IN	O
yellow	yellow	JJ	O
dashed	dash	VBN	O
lines	line	NNS	O
,	,	,	O
Ï-Ï	Ï-Ï	NNP	O
interactions	interaction	NNS	O
are	be	VBP	O
shown	show	VBN	O
with	with	IN	O
cyan	cyan	NNP	O
colour	colour	NN	O
.	.	.	O

The	the	DT	O
distance	distance	NN	O
between	between	IN	O
zinc	zinc	NN	O
metal	metal	NN	O
and	and	CC	O
interacting	interact	VBG	O
atom	atom	NN	O
is	be	VBZ	O
shown	show	VBN	O
with	with	IN	O
pink	pink	JJ	O
colour	colour	NN	O
.	.	.	O

Glide	Glide	NNP	O
XP	XP	NNP	O
Docking	Docking	NNP	O
scores	score	NNS	O
,	,	,	O
MM	MM	NNP	O
-	-	HYPH	O
GBSA	GBSA	NNP	O
ÎGbinding	îgbinde	VBG	O
energy	energy	NN	O
values	value	NNS	O
and	and	CC	O
selected	select	VBN	O
molecular	molecular	JJ	O
properties	property	NNS	O
of	of	IN	O
compounds	compound	NNS	O
1â10	1â10	CD	O
and	and	CC	O
AZA.aLogarithm	aza.alogarithm	NN	O
of	of	IN	O
the	the	DT	O
partition	partition	NN	O
coefficient	coefficient	NN	O
of	of	IN	O
the	the	DT	O
compound	compound	NN	O
between	between	IN	O
n	n	JJ	O
-	-	HYPH	O
octanol	octanol	NN	O
and	and	CC	O
water	water	NN	O
.bPercentage	.bPercentage	NFP	O
of	of	IN	O
human	human	JJ	O
oral	oral	JJ	O
absorption	absorption	NN	O
.cPolar	.cPolar	,	O
surface	surface	NN	O
area	area	NN	O
recommended	recommend	VBN	O
value	value	NN	O
â¤140Ã	â¤140Ã	NNP	O
		_SP	O
2	2	CD	O
.	.	.	O

CYTOWANIEWe	CYTOWANIEWe	NNS	O
have	have	VBP	O
also	also	RB	O
calculated	calculate	VBN	O
some	some	DT	O
molecular	molecular	JJ	O
descriptors	descriptor	NNS	O
commonly	commonly	RB	O
used	use	VBN	O
in	in	IN	O
absorption	absorption	NN	O
,	,	,	O
distribution	distribution	NN	O
,	,	,	O
metabolism	metabolism	NN	O
and	and	CC	O
excretion	excretion	NN	O
analysis	analysis	NN	O
.	.	.	O

As	as	IN	O
could	could	MD	O
be	be	VB	O
seen	see	VBN	O
from	from	IN	O
the	the	DT	O
table	table	NN	O
,	,	,	O
all	all	DT	O
of	of	IN	O
the	the	DT	O
new	new	JJ	O
compounds	compound	NNS	O
obey	obey	VBP	O
Lipinskiâs	lipinskiâs	CD	O
rule	rule	NN	O
of	of	IN	O
five	five	CD	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
an	an	DT	O
indication	indication	NN	O
of	of	IN	O
the	the	DT	O
drug	drug	NN	O
-	-	HYPH	O
likeness	likeness	NN	O
of	of	IN	O
a	a	DT	O
molecule	molecule	NN	O
,	,	,	O
and	and	CC	O
PSA	psa	NN	O
values	value	NNS	O
are	be	VBP	O
within	within	IN	O
the	the	DT	O
range	range	NN	O
that	that	IN	O
Veber	Veber	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	O

suggested	suggest	VBD	O
.	.	.	O

CYTOWANIEIn	CYTOWANIEIn	NNP	O
the	the	DT	O
current	current	JJ	O
study	study	NN	O
,	,	,	O
starting	start	VBG	O
from	from	IN	O
some	some	DT	O
chalcones	chalcone	NNS	O
,	,	,	O
design	design	NN	O
,	,	,	O
synthesis	synthesis	NN	O
and	and	CC	O
characterisation	characterisation	NN	O
of	of	IN	O
new	new	JJ	O
pyrazole	pyrazole	NN	O
derivatives	derivative	NNS	O
were	be	VBD	O
reported	report	VBN	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
synthesised	synthesise	VBN	O
compounds	compound	NNS	O
were	be	VBD	O
then	then	RB	O
evaluated	evaluate	VBN	O
for	for	IN	O
their	-PRON-	PRP$	O
inhibitory	inhibitory	JJ	O
properties	property	NNS	O
against	against	IN	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
and	and	CC	O
hCA	hca	CD	O
II	II	NNP	O
isoenzymes	isoenzyme	NNS	O
.	.	.	O

They	-PRON-	PRP	O
exhibited	exhibit	VBD	O
significant	significant	JJ	O
inhibitory	inhibitory	NN	O
features	feature	VBZ	O
at	at	IN	O
low	low	JJ	O
nanomolar	nanomolar	JJ	O
concentrations	concentration	NNS	O
ranging	range	VBG	O
between	between	IN	O
21.98	21.98	CD	O
and	and	CC	O
25.14ânM.	25.14ânm.	JJ	O
Molecular	molecular	JJ	O
docking	docking	NN	O
studies	study	NNS	O
further	further	RB	O
supported	support	VBD	O
observed	observe	VBN	O
inhibitory	inhibitory	JJ	O
profiles	profile	NNS	O
.	.	.	O

Compound	Compound	NNP	O
10	10	CD	O
which	which	WDT	O
had	have	VBD	O
slight	slight	JJ	O
hCA	hCA	VBN	O
I	-PRON-	PRP	O
versus	versus	IN	O
hCA	hca	CD	O
II	ii	CD	O
selectivity	selectivity	NN	O
,	,	,	O
binds	bind	NNS	O
with	with	IN	O
hCA	hCA	NNP	O
I	-PRON-	PRP	O
in	in	IN	O
similar	similar	JJ	O
orientations	orientation	NNS	O
with	with	IN	O
other	other	JJ	O
compounds	compound	NNS	O
but	but	CC	O
it	-PRON-	PRP	O
adopts	adopt	VBZ	O
different	different	JJ	O
conformation	conformation	NN	O
in	in	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
hCA	hca	CD	O
II	II	NNP	O
.	.	.	O

According	accord	VBG	O
to	to	IN	O
the	the	DT	O
in	in	IN	O
silico	silico	NN	O
molecular	molecular	JJ	O
properties	property	NNS	O
calculations	calculation	NNS	O
,	,	,	O
all	all	DT	O
compounds	compound	NNS	O
also	also	RB	O
obeyed	obey	VBD	O
the	the	DT	O
drug	drug	NN	O
likeness	likeness	NN	O
properties	property	NNS	O
.	.	.	O

The	the	DT	O
new	new	JJ	O
compounds	compound	NNS	O
presented	present	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
,	,	,	O
might	may	MD	O
be	be	VB	O
promising	promising	JJ	O
lead	lead	JJ	O
compounds	compound	NNS	O
for	for	IN	O
the	the	DT	O
development	development	NN	O
of	of	IN	O
more	more	JJR	O
selective	selective	JJ	O
and	and	CC	O
potent	potent	JJ	O
inhibitors	inhibitor	NNS	O
as	as	IN	O
alternatives	alternative	NNS	O
to	to	IN	O
the	the	DT	O
classical	classical	JJ	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
.	.	.	O

